-
Verrica Announces Proposed Public Offering of Common Stock
-
Verrica Announces Proposed Public Offering of Common Stock
-
UPDATE: RBC Capital Downgrades Verrica Pharmaceuticals (VRCA) to Sector Perform
-
UPDATE: RBC Capital Starts Verrica Pharmaceuticals (VRCA) at Outperform
-
Verrica Pharmaceuticals Announces Participation in the 2021 RBC Capital Markets Global Healthcare Conference
-
Verrica Pharmaceuticals Announces Participation in the 2021 RBC Capital Markets Global Healthcare Conference
-
Verrica Pharmaceuticals Inc. (VRCA) Prices 2.034M Share Common Offering at $14.75/Sh
-
Verrica Announces Pricing of Public Offering of Common Stock
-
Verrica Announces Pricing of Public Offering of Common Stock
-
Verrica Pharmaceuticals Inc. (VRCA) to Offer Common Stock
-
Verrica Announces Proposed Public Offering of Common Stock
-
Verrica Announces Proposed Public Offering of Common Stock
-
Verrica Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference and the RBC Capital Markets Global Healthcare Conference
-
Verrica Pharmaceuticals to Present at the Bank of America Merrill Lynch Global Healthcare Conference and the RBC Capital Markets Global Healthcare Conference
-
Verrica Pharmaceuticals Announces Participation in Upcoming Investor Conferences
-
Verrica Pharmaceuticals Announces Participation in Upcoming Investor Conferences